adenosine monophosphate has been researched along with Carotid Stenosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aknouche, S; Allard, J; Blanc, R; Ciccio, G; Delvoye, F; Desilles, JP; Escalard, S; Hebert, S; Labreuche, J; Maertens de Noordhout, A; Maier, B; Mazighi, M; Obadia, M; Olivot, JM; Piotin, M; Redjem, H; Sabben, C; Smajda, S; Thion, LA | 1 |
| Chen, JF; Hou, X; Liang, X; Zheng, J | 1 |
| Brandl, R; Deckmyn, H; Penz, SM; Reininger, AJ; Siess, W; Toth, O | 1 |
3 other study(ies) available for adenosine monophosphate and Carotid Stenosis
| Article | Year |
|---|---|
Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies.
Topics: Abciximab; Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Drug Administration Schedule; Emergencies; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stents; Time Factors; Treatment Outcome | 2021 |
Ecto-5'-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Analysis of Variance; Animals; Carotid Stenosis; Cognition Disorders; Corpus Callosum; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Leukoencephalopathies; Memory, Short-Term; Mice; Mice, Knockout; Neuroglia | 2015 |
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Atherosclerosis; Blood Coagulation Tests; Blood Platelets; Carotid Stenosis; Dose-Response Relationship, Drug; Hemorheology; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Time Factors; von Willebrand Factor | 2007 |